Jose I. Velasco-Fernandez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: March 03, 2026
Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: March 03, 2026
Apheresis CD8+CCR7+CD45RA- T-Cells as a Novel Biomarker Associated with CAR T-Cell Kinetics and Clinical Outcome.
Journal: International journal of molecular sciences
Published: December 04, 2025
Exploring the phenotypic expression of HLA-B27 in psoriatic arthritis.
Journal: Clinical rheumatology
Published: November 27, 2025
HLA-Cw6 in Psoriatic Arthritis: Clinical Phenotype and Therapeutic Impact.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: November 26, 2025
New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis.
Journal: Frontiers in immunology
Published: October 21, 2025
Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple Sclerosis.
Journal: International journal of molecular sciences
Published: June 24, 2025
Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis.
Journal: Frontiers in immunology
Published: June 17, 2025
Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 29, 2025
Corrigendum: Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.
Journal: Frontiers in immunology
Published: November 26, 2024
Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients.
Journal: International journal of molecular sciences
Published: November 19, 2024
Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.
Journal: Frontiers in immunology
Published: August 14, 2024
Last Updated: 09/26/2026